SEC Form 4/A · accession 0001078782-18-000111
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Andrew A Dahl
Officer — President/CEO
Period of report
Nov 28, 2012
Accepted (ET)
Feb 9, 2018 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 685,925 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 29, 2012, the reporting person mistakenly filed a Form 4 reporting an acquisition of 95,000 shares of common stock that did not in fact occur. As of November 28, 2012, the reporting person owned only 685,925 shares of common stock.